Information

[2012/09/26]
"The Industry-Academic-Government collaboration meeting Kazusa/Chiba 2012" was held at Kazusa academia hall.
[2012/03/22]
"The Research Result meeting Kazusa/Chiba 2012" was held at Kazusa academia hall. [Text in Japanese]
[2011/09/14]
"The Industry-Academic-Government collaboration meeting Kazusa/Chiba 2011" was held at Kazusa academia hall. [Text in Japanese]
[2011/03/29]
"The Research Result meeting Kazusa/Chiba 2011" had been called off.
[2010/09/29]
"The Industry-Academic-Government collaboration meeting Kazusa/Chiba 2010" was held at Kazusa academia hall. [Text in Japanese]
[2010/03/02]
"The Research Result meeting 2010 Kazusa/Chiba2010" was held at Perie hall. [Text in Japanese]
[2009/11/19]
"The Industry-Academic-Government collaboration meeting Kazusa/Chiba 2009" was held at Kazusa academia hall. [Text in Japanese]
[2009/07/13]
"The first biotechnology seminar Chiba 2009" was held. [Text in Japanese]
Main achievements

Outline of the program

The Kazusa/Chiba area was selected for the FY2009 MEXT City Area Program (development stage), and efforts have been made to form an industry-academia-government collaboration cluster to overcome immunological and allergic diseases based on advanced genome analysis technology.In this regional cluster, “Kazusa DNA Research Institute”, a research center of advanced genomic science, “Chiba University”, a global center for education and research in immune system regulation and treatment, and the “RIKEN Research Center for Allergy and Immunology”, a world leader in basic research, collaborate with each other to promote a wide spectrum of research activities from basic to clinical research and transfer the achievements to industry. The objectives are to contribute to the development of advanced medical treatments for immunological and allergic diseases that are still very much needed despite rapid progresses in medicine in recent years.The regional cluster is expected to support speedy and accurate diagnosis and selection of the best treatment method, eventually creating new businesses.

Formation of a new industry-academia-government collaboration cluster to overcome Immunological and allergic diseases based on advanced genome analysis